Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dian Lei Liu"'
Publikováno v:
International Journal of Biological Sciences, Vol 8, Iss 1, Pp 1-14 (2012)
Evodiamine has therapeutic potential against cancers. This study was designed to investigate whether combination therapy with gemcitabine and evodiamine enhanced antitumor efficacy in pancreatic cancer. In vitro application of the combination therapy
Externí odkaz:
https://doaj.org/article/ab5c097551e344acae404d5a1f262fd8
Autor:
Sheng-Zhang Lin, Wei-Tian Wei, Hui Chen, Kang-Jie Chen, Hong-Fei Tong, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Chun Guo, Dian-Lei Liu
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42146 (2012)
BACKGROUND: Emodin has been showed to induce apoptosis of pancreatic cancer cells and inhibit tumor growth in our previous studies. This study was designed to investigate whether emodin could inhibit the angiogenesis of pancreatic cancer tissues and
Externí odkaz:
https://doaj.org/article/dea8b836d3414a9eaf73a7345bf73aa1
Publikováno v:
Translational Cancer Research
Background Oridonin has been shown to exhibit potent anti-tumor activity, but the exact mechanisms underlying this activity remains unclear. Here, we investigated whether oridonin could synergistically enhance the activity of gemcitabine against BxPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239cb3957991cbca6bf9ffb84b585b7a
https://pubmed.ncbi.nlm.nih.gov/35117784
https://pubmed.ncbi.nlm.nih.gov/35117784
Autor:
Feng-Ping Pan, Yong Fei, Hong-Kun Zhou, Ziqiang Chen, Qing-Jiang Yu, He-Qi Bu, Yongquan Chu, Hao Zhang, Liang Chen, Lu-Ping Xu, Jie Pan, Dian-Lei Liu, Jian Tang, Shengzhang Lin
Publikováno v:
Oncology Reports
5-Aza-2′-deoxycytidine (5-Aza-CdR) is currently acknowledged as a demethylation drug, and causes a certain degree of demethylation in a variety of cancer cells, including pancreatic cancer cells. Emodin, a traditional Chinese medicine (TCM), is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2ee13c19463beff4086ac0c065ecbc
https://doi.org/10.3892/or.2016.4554
https://doi.org/10.3892/or.2016.4554
Autor:
DIAN-LEI LIU1, HE-QI BU2, HAI-MIN JIN1, JIN-FENG ZHAO1, YE LI1, HAI HUANG1 13738050750@163.com
Publikováno v:
Molecular Medicine Reports. 2014, Vol. 10 Issue 6, p3027-3034. 8p.
Publikováno v:
Molecular Medicine Reports. 10:3027-3034
Gemcitabine is a first‑line chemotherapeutic agent used in the treatment of pancreatic cancer; however resistance of the disease to the drug often develops over time. Agents that can either enhance the effects of gemcitabine, or help to overcome th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc98918654ff0c623c513d58af90f7ed
https://doi.org/10.3892/mmr.2014.2584
https://doi.org/10.3892/mmr.2014.2584
Publikováno v:
Advanced Materials Research. 852:17-22
Glucose oxidase (GOD) (EC 1.1.3.4) is an oxido-reductase that catalyses the oxidation action of glucose to hydrogen peroxide and D-glucono-δ-lactone [. GOD is widely used in the determination of free glucose in body fluids, in vegetal raw material a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39339647ee1bb68e4fdc2cae035f3b20
https://doi.org/10.4028/www.scientific.net/amr.852.17
https://doi.org/10.4028/www.scientific.net/amr.852.17
Autor:
Ye Li, Wei Zhang, Jian-Hong Zhang, Dian-Lei Liu, Hui Chen, Hong Li, Hongfei Tong, Kangjie Chen, Shengzhang Lin, Jiang Luo
Publikováno v:
International Journal of Oncology. 42:1189-1196
The aim of this study was to evaluate whether emodin can overcome the chemoresistance of the gemcitabine-resistant cancer cell line (Bxpc-3/Gem) in vitro. The cell line Bxpc-3/Gem was derived from the human pancreatic cancer cell line Bxpc-3. We foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e83c4ea20685720e31ccd3ef1582f88
https://doi.org/10.3892/ijo.2013.1839
https://doi.org/10.3892/ijo.2013.1839
Publikováno v:
Oncology reports. 31(2)
Oridonin, an active component isolated from Rabdosia rubescens, has been reported to exhibit antitumor effects. In the present study, we evaluated the antitumor activity and the mechanisms of action of oridonin in pancreatic cancer. Oridonin treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bacf8f367abfd842296b67b7c001b0f
https://pubmed.ncbi.nlm.nih.gov/24297112
https://pubmed.ncbi.nlm.nih.gov/24297112
Autor:
Hui Chen, Wei-Tian Wei, Hai-Bin Liu, Hong-Chun Guo, Zhong-Lin Ni, Dian-Lei Liu, Hongfei Tong, Shengzhang Lin, Zhao-Hong Wang, Kangjie Chen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e42146 (2012)
PLoS ONE, Vol 7, Iss 8, p e42146 (2012)
Background Emodin has been showed to induce apoptosis of pancreatic cancer cells and inhibit tumor growth in our previous studies. This study was designed to investigate whether emodin could inhibit the angiogenesis of pancreatic cancer tissues and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53fa35a69218b8598dec2a35883e09a7
https://pubmed.ncbi.nlm.nih.gov/22876305
https://pubmed.ncbi.nlm.nih.gov/22876305